IRIS
NOLASCO, SANTI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.257
AS - Asia 1.115
EU - Europa 938
AF - Africa 147
SA - Sud America 128
Continente sconosciuto - Info sul continente non disponibili 42
OC - Oceania 2
Totale 3.629
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.193
SG - Singapore 434
RU - Federazione Russa 371
CN - Cina 363
IT - Italia 351
KR - Corea 102
BR - Brasile 101
CI - Costa d'Avorio 78
VN - Vietnam 60
BD - Bangladesh 55
FR - Francia 46
CA - Canada 38
GB - Regno Unito 30
IE - Irlanda 27
IN - India 27
NL - Olanda 25
SN - Senegal 20
FI - Finlandia 19
NG - Nigeria 17
MX - Messico 14
JP - Giappone 13
HK - Hong Kong 12
DE - Germania 11
SE - Svezia 11
ES - Italia 9
PL - Polonia 9
BJ - Benin 8
TR - Turchia 8
ZA - Sudafrica 8
EC - Ecuador 7
IQ - Iraq 7
KE - Kenya 7
IR - Iran 6
PH - Filippine 5
VE - Venezuela 5
AR - Argentina 4
AT - Austria 4
CH - Svizzera 4
CO - Colombia 4
LT - Lituania 4
CR - Costa Rica 3
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
ID - Indonesia 2
MA - Marocco 2
OM - Oman 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 3.587
Salva come PNG Salva come JPEG
Città #
Singapore 294
Santa Clara 197
Hefei 190
Dallas 186
Moscow 156
San Jose 125
Ashburn 103
Seoul 101
Abidjan 78
Los Angeles 58
Beijing 52
Council Bluffs 49
Chicago 45
Milan 39
Civitanova Marche 36
Boardman 34
Lauterbourg 31
Dublin 27
Ho Chi Minh City 27
New York 27
Rome 25
Buffalo 21
Catania 20
Dakar 20
Orem 15
Lagos 14
São Paulo 14
Montreal 13
Naples 13
Palermo 13
Lappeenranta 12
Amsterdam 10
Brooklyn 10
Bari 9
Hanoi 9
Bologna 8
Cotonou 8
Johannesburg 8
Messina 8
Phoenix 8
Tokyo 8
Toronto 8
Charlotte 7
Chennai 7
Hong Kong 7
Turin 7
Warsaw 7
Biancavilla 6
Kochi 6
London 6
Seattle 6
Amiens 5
Atlanta 5
Figino 5
Manchester 5
Militello in Val di Catania 5
Pune 5
Querétaro 5
Rimini 5
Aci Catena 4
Denver 4
Fortaleza 4
Helsinki 4
Houston 4
Mexico City 4
Munich 4
Poplar 4
Reggio Emilia 4
Salvador 4
Stockholm 4
Treviso 4
Verona 4
Abuja 3
Amman 3
Ankara 3
Astoria 3
Baghdad 3
Boydton 3
Cagliari 3
Cleveland 3
Costabissara 3
Genoa 3
Giarre 3
Madrid 3
Mascalucia 3
Paris 3
Philadelphia 3
Praia Grande 3
Rio de Janeiro 3
San Francisco 3
Tehran 3
Abbiategrasso 2
Addis Ababa 2
Athens 2
Bitonto 2
Biên Hòa 2
Bogotá 2
Botucatu 2
Bruneck 2
Campinas 2
Totale 2.355
Salva come PNG Salva come JPEG
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 179
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 151
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 139
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 137
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 134
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 131
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 129
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 128
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 125
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 122
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 122
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 122
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 120
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 116
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 115
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 107
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 104
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 103
Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study 101
Are we overlooking the lung function in the definition of severe asthma remission? 98
Personalized Medicine in Asthma: Current Approach and Future Perspectives 97
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 93
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 90
“The Kafka’s Disease” 89
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 88
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis 84
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 83
Tezepelumab for asthma 83
Comparability of asthma control test scores between self and physician-administered test 81
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 73
Can humidified high flow reverse mucus plugging? 71
Advancing Clinical Remission in Severe Asthma: Efficacy of a Comprehensive Management Strategy Guided by Airway Inflammometry and Bioimaging [Migliorare la remissione clinica nell'asma grave: Efficacia di una strategia di gestione completa guidata dall'infiammometria delle vie aeree e dal bioimaging] 64
Switching Biological Therapies in Severe Asthma 60
Effect of the Arg16Gly β2‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study 29
High-flow nasal therapy vs conventional oxygen therapy in mild COVID-19 hypoxaemia: a Bayesian reanalysis of the COVID-HIGH Trial 22
Short-Term Effects of Dupilumab in Eosinophilic COPD 19
Effectiveness of Mepolizumab on Mucus Plugs and Clinical Outcomes in Severe Eosinophilic Asthma with and without Coexisting Bronchiectasis: A Prospective Pilot Study 13
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study 7
Totale 3.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202389 0 0 0 0 0 0 25 29 20 4 2 9
2023/2024224 6 29 22 19 6 47 4 21 3 8 44 15
2024/2025820 15 87 53 48 146 114 40 23 24 61 102 107
2025/20262.319 154 257 256 152 282 459 215 59 127 141 120 97
2026/2027177 86 91 0 0 0 0 0 0 0 0 0 0
Totale 3.629